ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
DRUGS MADE IN AMERICA ACQUISITION II CORP
10.15
+0.0100
0.10%
成交量：
15.27萬
成交額：
154.86萬
市值：
6.47億
市盈率：
49.66
高：
10.15
開：
10.14
低：
10.14
收：
10.14
52周最高：
10.20
52周最低：
9.86
股本：
6,370.00萬
流通股本：
5,025.83萬
量比：
87.46
換手率：
0.30%
股息：
- -
股息率：
- -
每股收益(TTM):
0.2044
每股收益(LYR):
0.1511
淨資產收益率：
--
總資產收益率：
-0.32%
市淨率：
-36.07
市盈率(LYR):
67.18
資料載入中...
總覽
公司
新聞資訊
公告
2026/08/14
季度報告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14
季度報告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/28
重要事件披露
Form 8-K - Current report
2026/04/15
年度報告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/04/03
重要事件披露
Form 8-K - Current report
2026/03/18
重要事件披露
Form 8-K - Current report
2026/03/06
重要事件披露
Form 8-K - Current report
2026/03/06
重要事件披露
Form 8-K - Current report
2025/11/18
季度報告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/18
重要事件披露
Form 8-K - Current report
2025/10/02
重要事件披露
Form 8-K - Current report
2025/09/30
重要事件披露
Form 8-K - Current report
2025/09/22
SEC問詢函
Form CORRESP - Correspondence
2025/09/22
SEC問詢函
Form CORRESP - Correspondence
2025/09/16
SEC問詢函
Form CORRESP - Correspondence
2025/09/16
[修訂]招股説明書
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/09/15
[修訂]招股説明書
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/09/05
[修訂]招股説明書
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/21
招股説明書
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/07/18
SEC問詢函
Form CORRESP - Correspondence
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/DMII/filings"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMII","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMII\",,,,,undefined,":{"symbol":"DMII","market":"US","secType":"STK","nameCN":"DRUGS MADE IN AMERICA ACQUISITION II CORP","latestPrice":10.15,"timestamp":1787601600000,"preClose":10.14,"halted":0,"volume":152724,"delay":0,"changeRate":0.0009861932938855806,"floatShares":50258300,"shares":63700000,"eps":0.204375,"marketStatus":"盤後交易","change":0.01,"latestTime":"08-24 17:30:45 EDT","open":10.14,"high":10.15,"low":10.14,"amount":1548648,"amplitude":0.000986,"askPrice":11.39,"askSize":100,"bidPrice":9.26,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.204375,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":10.14,"volumeRatio":87.46077},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMII\",,,,,undefined,":{"symbol":"DMII","floatShares":50258300,"roa":"-0.32%","roe":"--","lyrEps":0.151078,"volumeRatio":87.46077,"shares":63700000,"dividePrice":0,"high":10.15,"amplitude":0.000986,"preClose":10.14,"low":10.14,"week52Low":9.86,"pbRate":"-36.07","week52High":10.2,"institutionHeld":0,"latestPrice":10.15,"eps":0.204375,"divideRate":0,"volume":152724,"delay":0,"ttmEps":0.204375,"open":10.14,"prevYearClose":9.9,"prevWeekClose":10.14,"prevMonthClose":10.11,"prevQuarterClose":10.06,"fiveDayClose":10.13,"twentyDayClose":10.105,"sixtyDayClose":10.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMII\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"DMII","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":null},{"date":"2026-05-14","symbol":"DMII","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778788800000,"name":null,"time":"盤後","dateTimestamp":1778731200000,"actualEps":null},{"date":"2026-04-15","symbol":"DMII","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776283200000,"name":null,"time":"盤後","dateTimestamp":1776225600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMII\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMII\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMII\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMII","date":"2026-08-21","current":49.614679,"percent":0.536723,"low":-1442.152378,"twenty":-1436.389532,"median":-1275.121826,"eighty":74.948187,"high":156.692152,"avg":-684.526306,"sd":760.543686,"marketCap":645918000},"quantilePoints":[{"date":"2025-12-05","current":-1128.261237,"twenty":-1127.923771,"median":-1127.417572,"eighty":-1126.911373,"marketCap":513536000},{"date":"2025-12-12","current":-1421.982415,"twenty":-1423.423127,"median":-1421.982415,"eighty":-1187.005473,"marketCap":647225250},{"date":"2025-12-19","current":-1421.982415,"twenty":-1423.423127,"median":-1421.982415,"eighty":-1421.982415,"marketCap":647225250},{"date":"2025-12-26","current":-1426.30455,"twenty":-1423.423127,"median":-1422.702771,"eighty":-1421.982415,"marketCap":649192500},{"date":"2026-01-02","current":-1426.30455,"twenty":-1426.30455,"median":-1423.423127,"eighty":-1421.982415,"marketCap":649192500},{"date":"2026-01-09","current":-1428.465617,"twenty":-1426.30455,"median":-1423.423127,"eighty":-1421.982415,"marketCap":650176125},{"date":"2026-01-16","current":-1432.067397,"twenty":-1428.609688,"median":-1425.584194,"eighty":-1421.982415,"marketCap":651815500},{"date":"2026-01-23","current":-1436.389532,"twenty":-1429.762258,"median":-1426.30455,"eighty":-1421.982415,"marketCap":653782750},{"date":"2026-01-30","current":-1434.94882,"twenty":-1433.508108,"median":-1426.30455,"eighty":-1422.846842,"marketCap":653127000},{"date":"2026-02-06","current":-1442.152378,"twenty":-1434.94882,"median":-1428.10544,"eighty":-1423.423127,"marketCap":656405750},{"date":"2026-02-13","current":-1439.270955,"twenty":-1436.389532,"median":-1429.185973,"eighty":-1423.423127,"marketCap":655094250},{"date":"2026-02-20","current":-1442.152378,"twenty":-1439.270955,"median":-1429.185973,"eighty":-1423.423127,"marketCap":656405750},{"date":"2026-02-27","current":-1437.830243,"twenty":-1439.270955,"median":-1432.067397,"eighty":-1423.423127,"marketCap":654438500},{"date":"2026-03-06","current":-1437.830243,"twenty":-1439.270955,"median":-1433.508108,"eighty":-1423.423127,"marketCap":654438500},{"date":"2026-03-13","current":-1433.464886,"twenty":-1439.270955,"median":-1433.508108,"eighty":-1423.999411,"marketCap":652451577},{"date":"2026-03-20","current":-1434.94882,"twenty":-1438.69467,"median":-1433.508108,"eighty":-1425.440123,"marketCap":653127000},{"date":"2026-03-27","current":-1437.830243,"twenty":-1437.830243,"median":-1434.94882,"eighty":-1426.30455,"marketCap":654438500},{"date":"2026-04-02","current":-1439.270955,"twenty":-1437.830243,"median":-1434.94882,"eighty":-1426.30455,"marketCap":655094250},{"date":"2026-04-10","current":-1439.270955,"twenty":-1439.270955,"median":-1434.94882,"eighty":-1426.30455,"marketCap":655094250},{"date":"2026-04-17","current":156.692152,"twenty":-1439.270955,"median":-1434.94882,"eighty":-1426.30455,"marketCap":656077875},{"date":"2026-04-24","current":152.287888,"twenty":-1439.270955,"median":-1434.94882,"eighty":-1423.711269,"marketCap":637637000},{"date":"2026-05-01","current":152.440023,"twenty":-1439.270955,"median":-1434.94882,"eighty":-1423.423127,"marketCap":638274000},{"date":"2026-05-08","current":152.363956,"twenty":-1439.270955,"median":-1433.508108,"eighty":-1421.982415,"marketCap":637955500},{"date":"2026-05-15","current":152.592159,"twenty":-1439.270955,"median":-1433.508108,"eighty":-1187.005473,"marketCap":638911000},{"date":"2026-05-22","current":74.577156,"twenty":-1438.982813,"median":-1433.464886,"eighty":74.488109,"marketCap":640185000},{"date":"2026-05-29","current":74.725568,"twenty":-1437.830243,"median":-1432.067397,"eighty":74.651362,"marketCap":641459000},{"date":"2026-06-05","current":74.725568,"twenty":-1437.830243,"median":-1431.347041,"eighty":74.725568,"marketCap":641459000},{"date":"2026-06-12","current":74.799775,"twenty":-1437.830243,"median":-1429.185973,"eighty":74.725568,"marketCap":642096000},{"date":"2026-06-18","current":74.948187,"twenty":-1437.830243,"median":-1428.465617,"eighty":74.799775,"marketCap":643370000},{"date":"2026-06-26","current":74.725568,"twenty":-1437.830243,"median":-1427.024906,"eighty":74.799775,"marketCap":641459000},{"date":"2026-07-02","current":74.725568,"twenty":-1437.830243,"median":-1426.30455,"eighty":74.799775,"marketCap":641459000},{"date":"2026-07-10","current":74.948187,"twenty":-1437.830243,"median":-1426.30455,"eighty":74.873536,"marketCap":643370000},{"date":"2026-07-17","current":74.873981,"twenty":-1437.830243,"median":-1424.143483,"eighty":74.873981,"marketCap":642733000},{"date":"2026-07-24","current":74.873981,"twenty":-1437.830243,"median":-1423.423127,"eighty":74.873981,"marketCap":642733000},{"date":"2026-07-31","current":75.096599,"twenty":-1437.830243,"median":-1423.423127,"eighty":74.896243,"marketCap":644644000},{"date":"2026-08-07","current":75.022393,"twenty":-1437.253959,"median":-1421.982415,"eighty":74.948187,"marketCap":644007000},{"date":"2026-08-14","current":75.170805,"twenty":-1436.389532,"median":-1421.982415,"eighty":74.970449,"marketCap":645281000},{"date":"2026-08-21","current":49.614532,"twenty":-1436.389532,"median":-1275.121826,"eighty":74.948187,"marketCap":645918000}],"updateTime":1787574949571},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"DMII\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"21621447","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026090017-DMII","pdf_url":"","pub_time":1786680000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMII","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/0001213900-26-090017-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea0301690-10q_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0301690-10q_drugs2.htm","type":"10-Q","id":"NTFILEG1DuussthVY5syPn","market":"us","size":470401},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea030169001ex31-1.htm","primary":false,"translateUrl":"","linkName":"ea030169001ex31-1.htm","type":"EX-31.1","id":"NTFILEFTLNdqp4xU1ttKHb","market":"us","size":11762},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea030169001ex31-2.htm","primary":false,"translateUrl":"","linkName":"ea030169001ex31-2.htm","type":"EX-31.2","id":"NTFILEGUr2BgLGrD7eRwXQ","market":"us","size":11799},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea030169001ex32-1.htm","primary":false,"translateUrl":"","linkName":"ea030169001ex32-1.htm","type":"EX-32.1","id":"NTFILEGNrG4tQd21Xa6YEg","market":"us","size":4576},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea030169001ex32-2.htm","primary":false,"translateUrl":"","linkName":"ea030169001ex32-2.htm","type":"EX-32.2","id":"NTFILEFd4dV6wtjDcPated","market":"us","size":4990}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"季度報告","pubTime":"2026-08-14 12:00","pubTimestamp":1786680000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21260130","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026056651-DMII","pdf_url":"","pub_time":1778731200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMII","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/0001213900-26-056651-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea0290022-10q_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0290022-10q_drugs2.htm","type":"10-Q","id":"NTFILEAnspK2RFBJabmQQa","market":"us","size":410233},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea029002201ex31-1.htm","primary":false,"translateUrl":"","linkName":"ea029002201ex31-1.htm","type":"EX-31.1","id":"NTFILE3YPAar8zbHwPBTtm","market":"us","size":18287},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea029002201ex31-2.htm","primary":false,"translateUrl":"","linkName":"ea029002201ex31-2.htm","type":"EX-31.2","id":"NTFILEC2ZYDXtPBqUDuRxt","market":"us","size":18301},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea029002201ex32-1.htm","primary":false,"translateUrl":"","linkName":"ea029002201ex32-1.htm","type":"EX-32.1","id":"NTFILE79d3QnatCi3h8kA2","market":"us","size":7363},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea029002201ex32-2.htm","primary":false,"translateUrl":"","linkName":"ea029002201ex32-2.htm","type":"EX-32.2","id":"NTFILE2vvoCAp87FWrE8VS","market":"us","size":7383}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"季度報告","pubTime":"2026-05-14 12:00","pubTimestamp":1778731200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21169870","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026048687-DMII","pdf_url":"","pub_time":1777348800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/0001213900-26-048687-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"STATEMENT OF WORK BETWEEN AND BY DRUGS MADE IN AMERICA ACQUISITION II CORP. AND","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea028797501ex10-1.htm","primary":true,"translateUrl":"","linkName":"ea028797501ex10-1.htm","type":"EX-10.1","id":"NTFILE9dv99ckJs85Sjdpt","market":"us","size":12097},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea0287975-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0287975-8k_drugs2.htm","type":"8-K","id":"NTFILE5o9J8qVUPv11BnEx","market":"us","size":39585},{"description":"CEO COMPENSATION AGREEMENT BETWEEN AND BY DRUGS MADE IN AMERICA ACQUISITION II C","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea028797501ex10-2.htm","primary":false,"translateUrl":"","linkName":"ea028797501ex10-2.htm","type":"EX-10.2","id":"NTFILE3873M72KNy4fd5LQ","market":"us","size":10598},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea028797501_ex10-1img1.jpg","primary":false,"translateUrl":"","linkName":"ea028797501_ex10-1img1.jpg","type":"GRAPHIC","id":"NTFILEE9VYDoyfJgmrpwv7","market":"us","size":3094}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-04-28 12:00","pubTimestamp":1777348800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：簽訂重大最終協議；項目9.01：財務報表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21007595","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026044055-DMII","pdf_url":"","pub_time":1776225600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"DMII","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/0001213900-26-044055-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea0285468-10k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0285468-10k_drugs2.htm","type":"10-K","id":"NTFILEHizYowV9hwVaRDbq","market":"us","size":934855},{"description":"DESCRIPTION OF THE COMPANY'S SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex4-5.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex4-5.htm","type":"EX-4.5","id":"NTFILEFqvi2hZi25n3ykfQ","market":"us","size":70211},{"description":"INSIDER TRADING POLICY","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex-19.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex-19.htm","type":"EX-19","id":"NTFILEGbJV4DDXDQ8ME17b","market":"us","size":40514},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex31-1.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex31-1.htm","type":"EX-31.1","id":"NTFILEDUWC6FBUNdx7tA2S","market":"us","size":9116},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex31-2.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex31-2.htm","type":"EX-31.2","id":"NTFILE2vot9kPGo21P4ApY","market":"us","size":9271},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex32-1.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex32-1.htm","type":"EX-32.1","id":"NTFILE4rebgbj7hwrh4QF5","market":"us","size":3371},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex32-2.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex32-2.htm","type":"EX-32.2","id":"NTFILEGJcSuvMmE7ALhxU1","market":"us","size":3337},{"description":"CLAWBACK POLICY","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex97-1.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex97-1.htm","type":"EX-97.1","id":"NTFILENrzu28E1ds7aHuwA","market":"us","size":24966}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"年度報告","pubTime":"2026-04-15 12:00","pubTimestamp":1776225600,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20960867","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026039986-DMII","pdf_url":"","pub_time":1775188800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/0001213900-26-039986-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"DEFINITIVE INVESTMENT AND SPONSOR TRANSITION AGREEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/ea028511201ex10-1.htm","primary":true,"translateUrl":"","linkName":"ea028511201ex10-1.htm","type":"EX-10.1","id":"NTFILEF3xXzpbRYhqbaZqg","market":"us","size":36711},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/ea0285112-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0285112-8k_drugs2.htm","type":"8-K","id":"NTFILE3QRJzhi4tv7wreso","market":"us","size":35545},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/ea028511201_ex10-1img1.jpg","primary":false,"translateUrl":"","linkName":"ea028511201_ex10-1img1.jpg","type":"GRAPHIC","id":"NTFILE2yfEY9UFTQ4fwSRs","market":"us","size":2446}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-04-03 12:00","pubTimestamp":1775188800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：簽訂重大最終協議；第2.03項：直接財務義務或註冊人資產負債表外安排下的義務的產生；項目9.01：財務報表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20848755","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026029050-DMII","pdf_url":"","pub_time":1773777668000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/0001213900-26-029050-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LETTER OF INTENT DATED MARCH 5, 2026 BETWEEN DRUGS MADE IN AMERICA ACQUISITION I","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea028195901ex10-1.htm","primary":true,"translateUrl":"","linkName":"ea028195901ex10-1.htm","type":"EX-10.1","id":"NTFILEC7jMsAGBufwDZmyz","market":"us","size":32731},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea0281959-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0281959-8k_drugs2.htm","type":"8-K","id":"NTFILEDCBY8gsvsVxPq5WL","market":"us","size":36164},{"description":"ADDENDUM TO LETTER OF INTENT DATED MARCH 9, 2026","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea028195901ex10-2.htm","primary":false,"translateUrl":"","linkName":"ea028195901ex10-2.htm","type":"EX-10.2","id":"NTFILEEpquKy9cpr2oETxN","market":"us","size":24000},{"description":"BRIDGE FINANCING CONVERTIBLE PROMISSORY NOTE DATED MARCH 11, 2026","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea028195901ex10-3.htm","primary":false,"translateUrl":"","linkName":"ea028195901ex10-3.htm","type":"EX-10.3","id":"NTFILE8iXocCMEAXjMKdiU","market":"us","size":13234}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-18 04:01","pubTimestamp":1773777668,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：簽訂重大最終協議；第2.03項：直接財務義務或註冊人資產負債表外安排下的義務的產生；項目8.01：其他事件；項目9.01：財務報表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20810363","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026024763-DMII","pdf_url":"","pub_time":1772773200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024763/0001213900-26-024763-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024763/ea028047201-8k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea028047201-8k_drugs2.htm","type":"8-K","id":"NTFILE22b7MC3fnDjFba8s","market":"us","size":31573}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-06 13:00","pubTimestamp":1772773200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events","summary_zh":"項目8.01：其他事項","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20808546","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026024387-DMII","pdf_url":"","pub_time":1772773200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024387/0001213900-26-024387-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024387/ea0280265-8k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0280265-8k_drugs2.htm","type":"8-K","id":"NTFILEFPZn67FJmQiQB9zs","market":"us","size":37493}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-06 13:00","pubTimestamp":1772773200,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02項：董事或某些高級職員的離職；選舉董事；若干人員的委任：若干人員的補償安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20497254","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025112095-DMII","pdf_url":"","pub_time":1763442000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMII","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/0001213900-25-112095-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea0265078-10q_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0265078-10q_drugs2.htm","type":"10-Q","id":"NTFILEFWgy3ptpem4sFsim","market":"us","size":458709},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex31-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex31-1_drugs2.htm","type":"EX-31.1","id":"NTFILEGfYLbLov4EGAFzYJ","market":"us","size":11978},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex31-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex31-2_drugs2.htm","type":"EX-31.2","id":"NTFILE4LhuMabvJXntHd9D","market":"us","size":11968},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex32-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex32-1_drugs2.htm","type":"EX-32.1","id":"NTFILE3Buo4FJjDJ489ngD","market":"us","size":4610},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex32-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex32-2_drugs2.htm","type":"EX-32.2","id":"NTFILEww3tLTisfQkGtoT2","market":"us","size":4625}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"季度報告","pubTime":"2025-11-18 13:00","pubTimestamp":1763442000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20497251","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025111706-DMII","pdf_url":"","pub_time":1763442000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025111706/0001213900-25-111706-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025111706/ea0265998-8k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0265998-8k_drugs2.htm","type":"8-K","id":"NTFILE25oRbezbZjk4FjQ2","market":"us","size":47195}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-18 13:00","pubTimestamp":1763442000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02項：董事或某些高級職員的離職；選舉董事；若干人員的委任：若干人員的補償安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20497247","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025095513-DMII","pdf_url":"","pub_time":1759377600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/0001213900-25-095513-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BALANCE SHEET DATED SEPTEMBER 26, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/ea025966201ex99-1_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea025966201ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILEAAA27QSyHwP3JTXw","market":"us","size":114250},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/ea0259662-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0259662-8k_drugs2.htm","type":"8-K","id":"NTFILE3phmxEJ9FxAR9JAi","market":"us","size":18513}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-10-02 12:00","pubTimestamp":1759377600,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他事件；項目9.01：財務報表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20224112","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025093224-DMII","pdf_url":"","pub_time":1759181333000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/0001213900-25-093224-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN THE COMPANY AND","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex1-1_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea025896901ex1-1_drugs2.htm","type":"EX-1.1","id":"NTFILE91h2b3CiDY6bbbxG","market":"us","size":263251},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea0258969-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0258969-8k_drugs2.htm","type":"8-K","id":"NTFILECpPWdDL7ngeHKEWn","market":"us","size":45247},{"description":"AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex3-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex3-1_drugs2.htm","type":"EX-3.1","id":"NTFILE3habBRVesg3EUJWD","market":"us","size":286799},{"description":"RIGHTS AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN THE COMPANY AND CONTI","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex4-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex4-1_drugs2.htm","type":"EX-4.1","id":"NTFILE8zB2dsP7dqYC6iZ7","market":"us","size":68156},{"description":"LETTER AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG THE COMPANY, DRUGS MADE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-1_drugs2.htm","type":"EX-10.1","id":"NTFILE6FGWQwdP2H4r7wAi","market":"us","size":53854},{"description":"INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG TH","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-2_drugs2.htm","type":"EX-10.2","id":"NTFILEEph96NTSg4q9Qnoe","market":"us","size":98263},{"description":"REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG THE COMPAN","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-3_drugs2.htm","type":"EX-10.3","id":"NTFILEApgAHkW6PJGUZxr5","market":"us","size":105386},{"description":"PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-4_drugs2.htm","type":"EX-10.4","id":"NTFILEBCTERJ8ZYdg3CLcV","market":"us","size":28320},{"description":"PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN T","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-5_drugs2.htm","type":"EX-10.5","id":"NTFILECccisa3Y8JEVT8BQ","market":"us","size":30246},{"description":"FORM OF INDEMNITY AGREEMENT BY AND BETWEEN THE COMPANY AND EACH OF THE OFFICERS","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-6_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-6_drugs2.htm","type":"EX-10.6","id":"NTFILE4YbLeUaFfBVUFiyA","market":"us","size":81365},{"description":"ADMINISTRATIVE SERVICES AGREEMENT, DATED AS OF SEPTEMBER 24, 2025, BY AND BETWEE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-7_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-7_drugs2.htm","type":"EX-10.7","id":"NTFILE22eXsvrs1ULX2nfL","market":"us","size":10653},{"description":"PRESS RELEASE DATED SEPTEMBER 25, 2025","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex99-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILE9KtkrrkqQ52Q844k","market":"us","size":7950},{"description":"PRESS RELEASE DATED SEPTEMBER 26, 2025","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex99-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex99-2_drugs2.htm","type":"EX-99.2","id":"NTFILE9eydC7q9PCjpaEhP","market":"us","size":8483},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILEFVMS7SRHEUQcoEYN","market":"us","size":12566}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-30 05:28","pubTimestamp":1759181333,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：簽訂重大最終協議；第3.02項：未經登記的股本證券銷售；第5.02項：董事或某些高級職員的離職；選舉董事；若干人員的委任：若干人員的補償安排；第5.03項：公司章程或章程的修訂；財政年度的變化；項目8.01：其他事件；項目9.01：財務報表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20710956","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025089923-DMII","pdf_url":"","pub_time":1758513600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMII","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025089923/0001213900-25-089923-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025089923/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEFrkDXuYmM6di1kFT","market":"us","size":10040}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2025-09-22 12:00","pubTimestamp":1758513600,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20710905","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025089929-DMII","pdf_url":"","pub_time":1758513600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMII","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025089929/0001213900-25-089929-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025089929/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE4ygUgQYaBeRQc3W3","market":"us","size":7333}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2025-09-22 12:00","pubTimestamp":1758513600,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20710910","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025088056-DMII","pdf_url":"","pub_time":1757995200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMII","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088056/0001213900-25-088056-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088056/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEDMRgQM3mtm1JWx19","market":"us","size":10701},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088056/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEHFUTows9Us3NG6n2","market":"us","size":3069}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2025-09-16 12:00","pubTimestamp":1757995200,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20175248","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025088044-DMII","pdf_url":"","pub_time":1757995200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMII","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/0001213900-25-088044-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/ea0234544-09.htm","primary":true,"translateUrl":"","linkName":"ea0234544-09.htm","type":"S-1/A","id":"NTFILE8eY3mGQXSc9VdwJe","market":"us","size":4594239},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/ea023454409ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023454409ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEDDZikXknjnFhkaqW","market":"us","size":49929}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2025-09-16 12:00","pubTimestamp":1757995200,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20170097","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025087444-DMII","pdf_url":"","pub_time":1757908800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMII","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/0001213900-25-087444-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea0234544-08.htm","primary":true,"translateUrl":"","linkName":"ea0234544-08.htm","type":"S-1/A","id":"NTFILEFSsdqzvwEsKsDGur","market":"us","size":4591246},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea023454408ex1-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454408ex1-1_drugs2.htm","type":"EX-1.1","id":"NTFILEDLFBayWvssPm78kd","market":"us","size":252537},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea023454408ex5-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454408ex5-1_drugs2.htm","type":"EX-5.1","id":"NTFILEDea4x5sejXM35m17","market":"us","size":55574},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE6WRa3G1hZM2S42AC","market":"us","size":9247},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE7qBsppfRiaKmrjMw","market":"us","size":12840}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2025-09-15 12:00","pubTimestamp":1757908800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20136176","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025085167-DMII","pdf_url":"","pub_time":1757044800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMII","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修訂]招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/0001213900-25-085167-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea0234544-06.htm","primary":true,"translateUrl":"","linkName":"ea0234544-06.htm","type":"S-1/A","id":"NTFILE2TAUASXtkgmdDQQb","market":"us","size":4565347},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE7x8wmGwmtF7BZD48","market":"us","size":250437},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex5-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex5-1_drugs2.htm","type":"EX-5.1","id":"NTFILEEWEjbY6ARPZbG9sf","market":"us","size":39364},{"description":"OPINION OF LOEB & LOEB LLP","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex5-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex5-2_drugs2.htm","type":"EX-5.2","id":"NTFILE9aDU6hDfR4F8ZopZ","market":"us","size":11529},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex23-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex23-1_drugs2.htm","type":"EX-23.1","id":"NTFILEDZA5vghouTiMmW3g","market":"us","size":1909},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE5w4XddGU94m1GCMH","market":"us","size":11028},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILED5WPUJqthEWcYg3T","market":"us","size":12588},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILEHpPyXaS17TdaRzFk","market":"us","size":12991}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"[修訂]招股説明書","pubTime":"2025-09-05 12:00","pubTimestamp":1757044800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20136178","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025065837-DMII","pdf_url":"","pub_time":1753070400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"DMII","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股説明書","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/0001213900-25-065837-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea0234544-04.htm","primary":true,"translateUrl":"","linkName":"ea0234544-04.htm","type":"S-1","id":"NTFILE755Uv9YP7QzD9uBd","market":"us","size":4544925},{"description":"MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex3-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex3-1_drugs2.htm","type":"EX-3.1","id":"NTFILEBssNQB3B5D9eC9dx","market":"us","size":239206},{"description":"FORM OF AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex3-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex3-2_drugs2.htm","type":"EX-3.2","id":"NTFILE2FdcuaPbUxXWj498","market":"us","size":283955},{"description":"SPECIMEN UNIT CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-1_drugs2.htm","type":"EX-4.1","id":"NTFILE7gMyXmuR2hTPzkVi","market":"us","size":21282},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-2_drugs2.htm","type":"EX-4.2","id":"NTFILEAqJRkNqbx9kVLvsC","market":"us","size":20026},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-4_drugs2.htm","type":"EX-4.4","id":"NTFILE97Uu5fJzoF5zBbde","market":"us","size":68499},{"description":"PROMISSORY NOTE, DATED AS OF SEPTEMBER 5, 2024, AS AMENDED, ISSUED TO DRUGS MADE","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-1_drugs2.htm","type":"EX-10.1","id":"NTFILEHCjaudcTJvZvrHR6","market":"us","size":27200},{"description":"SECURITIES SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 10, 2024, BETWEEN THE REGISTR","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-2_drugs2.htm","type":"EX-10.2","id":"NTFILEGxQTCsQEQLSVrWF3","market":"us","size":45653},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-3_drugs2.htm","type":"EX-10.3","id":"NTFILEJ5jcEmQwe3d8sMua","market":"us","size":44793},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-4_drugs2.htm","type":"EX-10.4","id":"NTFILEAyuW6TrcE31YBJpe","market":"us","size":96880},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT AMONG THE REGISTRANT, DRUGS MADE IN AMERIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-5_drugs2.htm","type":"EX-10.5","id":"NTFILE7mz8ibWbjLevWLYV","market":"us","size":103172},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-6_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-6_drugs2.htm","type":"EX-10.6","id":"NTFILEGujztQdNTnGeZov5","market":"us","size":27395},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND CANTOR FITZG","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-7_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-7_drugs2.htm","type":"EX-10.7","id":"NTFILE5CBU3coNB3sRegJT","market":"us","size":28354},{"description":"FORM OF INDEMNITY AGREEMENT","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-8_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-8_drugs2.htm","type":"EX-10.8","id":"NTFILEFKbm5YebFv2GNapi","market":"us","size":81257},{"description":"FORM OF ADMINISTRATIVE SERVICES AGREEMENT BY AND BETWEEN THE REGISTRANT AND AN A","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-9_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-9_drugs2.htm","type":"EX-10.9","id":"NTFILEF9NsLyjLv8zXnPRR","market":"us","size":10757},{"description":"FORM OF CODE OF CONDUCT","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex14_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex14_drugs2.htm","type":"EX-14","id":"NTFILEAJq6NJSLGtxG3HR3","market":"us","size":49115},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex23-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex23-1_drugs2.htm","type":"EX-23.1","id":"NTFILE3WwRDHeAzWpy6UN6","market":"us","size":2144},{"description":"CONSENT OF CATHERINE DO","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILE8YKa6Dcv7eAnws1b","market":"us","size":2188},{"description":"CONSENT OF G. SRIDHAR PRASAD","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-2_drugs2.htm","type":"EX-99.2","id":"NTFILEBbZZEr6AKmXQEdt4","market":"us","size":2104},{"description":"CONSENT OF MYRON W. SHULGAN","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-3_drugs2.htm","type":"EX-99.3","id":"NTFILEENA7BJxoNwPGoxt9","market":"us","size":2269},{"description":"FORM OF AUDIT COMMITTEE CHARTER","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-4_drugs2.htm","type":"EX-99.4","id":"NTFILE6ihi3tjp3woNgMet","market":"us","size":38650},{"description":"FORM OF COMPENSATION COMMITTEE CHARTER","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-5_drugs2.htm","type":"EX-99.5","id":"NTFILEBTb3xyj7MNmUeko1","market":"us","size":31779},{"description":"FILING FEE TABLE","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex-fee_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex-fee_drugs2.htm","type":"EX-FILING FEES","id":"NTFILEGvQVm6QjDuRYf3Qi","market":"us","size":20431},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILEHfpABtJGntSwaaqQ","market":"us","size":9129},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ex3-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_002.jpg","type":"GRAPHIC","id":"NTFILEB9UbYUjheeL1ya7V","market":"us","size":7198}],"type_name":"招股註冊","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股註冊","earn_infos":[],"event_type":"important_notice","event_name":"招股説明書","pubTime":"2025-07-21 12:00","pubTimestamp":1753070400,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20710927","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025065839-DMII","pdf_url":"","pub_time":1752811200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMII","title":"Form CORRESP - Correspondence","titleType":"SEC問詢函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065839/0001213900-25-065839-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065839/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE2K37663UEZwFhs2J","market":"us","size":8337},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065839/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEBCLBs1yw6JnaNy1f","market":"us","size":9366}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC問詢函","pubTime":"2025-07-18 12:00","pubTimestamp":1752811200,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}